Capmatinib Recruiting Phase 4 Trials for Advanced Solid Tumors Which Are cMET-dependent Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03040973Roll-over Study for Patients With cMET-dependent Malignancies Who Previously Completed a Novartis Capmatinib Study